Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Bone Marrow Transplantation

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1701768PMID 10382955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets

  1998cited by this paper
• Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?

  1996cited by this paper
• Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis.

  1996cited by this paper
• Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

  1996cited by this paper
• Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

  1996cited by this paper
• HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.

  1996cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• Leukemia relapse after allogeneic bone marrow transplantation: a review.

  1994cited by this paper
• Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.

  1994cited by this paper
• Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

  1994cited by this paper
• Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

  1994cited by this paper
• HLA-DP and allogeneic bone marrow transplantation.

  1994cited by this paper
• Mechanisms of T cell recognition of alloantigen. The role of peptides.

  1994cited by this paper
• The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

  1993cited by this paper
• Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.

  1993cited by this paper
• Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.

  1993cited by this paper
• Adoptive immunotherapy for recurrent CML after BMT.

  1993cited by this paper
• Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose.

  1993cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.

  1990cited by this paper
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

  1990cited by this paper
• Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors

  1990cited by this paper
• A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation.

  1990cited by this paper
• Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.

  1989cited by this paper
• Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect

  1988cited by this paper
• Natural killer (NK) cell sensitivity of phorbol ester‐differentiated tumour cells correlates with disease activity in chronic B‐lymphocytic leukaemia

  1982cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper

• Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells

  2024cites this paper
• T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation

  2023cites this paper
• Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation

  2023cites this paper
• Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia

  2021cites this paper
• Impact of HLA-DPB1 Matching on Outcome of Unrelated Transplant for Hematologic Malignant Diseases: A Systematic Review and Meta-analysis.

  2019cites this paper
• The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations.

  2018cites this paper
• HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.

  2017cites this paper
• Type : Spotlight

  2017cites this paper
• HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities.

  2017cites this paper
• Impact of HLA-DPB1 Matching in Unrelated Allogeneic Stem Cell Transplantation: Results of Two Centers From Turkey

  2017cites this paper
• HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation

  2017cites this paper
• In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors

  2014cites this paper
• Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.

  2014cites this paper
• Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.

  2014cites this paper
• disease specificity of T cells infiltrating the skin during acute graft-versus-host Permissive, nonpermissive HLA-DPB1 epitope disparities and the

  2014cites this paper
• Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.

  2013cites this paper
• Allogeneic transplantation: when is a mismatch better than a match?

  2013cites this paper
• Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.

  2013cites this paper
• non-permissive mismatches for hematological stem cell transplantation A T cell epitope encoded by a subset of HLA-DPB1 alleles determines

  2013cites this paper
• HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.

  2013cites this paper
• Permissive, nonpermissive HLA-DPB1 epitope disparities and the specificity of T cells infiltrating the skin during acute graft-versus-host disease.

  2011cites this paper
• Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

  2010cites this paper
• Relationship between HLA‐DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?

  2009cites this paper
• HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia

  2008cites this paper
• Greffes allogniques partir de donneurs non apparents

  2008cites this paper
• unrelated donor stem cell transplants HLA-DPB1 matching status has significant implications for recipients of

  2008cites this paper
• Greffes allogéniques à partir de donneurs non apparentés

  2007cites this paper
• The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

  2007cites this paper
• HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention

  2007cites this paper
• The importance of HLA-DPB 1 in unrelated donor hematopoietic cell

  2007cites this paper
• NK cell-based immunotherapies against tumors

  2006cites this paper
• Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality

  2006cites this paper
• HLA-DPB 1 matching status has significant implications for recipients of unrelated donor stem cell transplants

  2006cites this paper
• HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.

  2006cites this paper
• A new carboxamide compound exerts immuno‐suppressive activity by inhibiting dendritic cell maturation

  2005cites this paper
• Development of a sample bank and clinical database for the retrospective analysis of unrelated bone marrow transplants : a pilot study of 138 transplants using RSCA for high resolution HLA matching

  2005cites this paper
• AT-cell epitope encoded by a subset of HLA-DPB 1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation

  2004cites this paper
• Preparation of Genetically Homogeneous Antigen-Specific Thymidine Kinase Positive T-Lymphocyte Clones for the Control of Alloreactivity Post-Bone Marrow Transplantation

  2004cites this paper
• The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation

  2003cites this paper
• A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.

  2003cites this paper
• Unrelated donor transplants DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

  2002cites this paper
• DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

  2002cites this paper
• Short-form HLA-DP typing with 48 primer mixes using the polymerase chain reaction and sequence-specific primers.

  2001cites this paper
• Improving the outcome of unrelated donor stem cell transplantation by molecular matching.

  2001cites this paper
• Cytokine‐Driven Differentiation of Blasts from Patients with Acute Myelogenous and Lymphoblastic Leukemia into Dendritic Cells

  2000cites this paper